Successful immune tolerance induction using efanesoctocog alfa in severe hemophilia A: a case series
Journal of Thrombosis and Haemostasis · 2026-11 · 24 (11) · 3939-3942
DOI: 10.1016/j.jtha.2026.08.022 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026-11. Verfasst von Aqsa Ashraf und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hematology-Oncology Section, Department of Internal Medicine, College of Medicine, University of Oklahoma Health Campus, Oklahoma City, Oklahoma, USA…. Hauptthemen laut MEDLINE: Hemophilia A, Factor VIII, Immune Tolerance, Blood Coagulation Factor Inhibitors. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The University of Oklahoma Health Sciences.
Abstract (Originalsprache)
The development of neutralizing factor VIII (FVIII) inhibitors remains a major therapeutic challenge in severe hemophilia A. We report 2 patients with complex inhibitor histories who achieved rapid, sustained inhibitor eradication with efanesoctocog alfa. Immune tolerance induction was initiated at 100 U/kg 3 times weekly, with subsequent dose reduction after inhibitor clearance. Inhibitor titers declined to undetectable levels (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hematology-Oncology Section, Department of Internal Medicine, College of Medicine, University of Oklahoma Health Campus, Oklahoma City, Oklahoma, USA. Electronic address: aqsa-ashraf@ou.edu.
- Department of Internal Medicine, College of Medicine, University of Oklahoma Health Campus, Oklahoma City, Oklahoma, USA.
- Department of Pediatrics, Oklahoma Center for Bleeding and Clotting Disorders, University of Oklahoma Health Campus, Oklahoma City, Oklahoma, USA.
- Hematology-Oncology Section, Department of Internal Medicine, College of Medicine, University of Oklahoma Health Campus, Oklahoma City, Oklahoma, USA.
Förderung
- The University of Oklahoma Health Sciences
Zitieren
APA
Ashraf, A., Kuhlman, R., Khan, O., & Nusrat, S. (2026). Successful immune tolerance induction using efanesoctocog alfa in severe hemophilia A: a case series. Journal of Thrombosis and Haemostasis, 24(11), 3939-3942. https://doi.org/10.1016/j.jtha.2026.08.022
Vancouver
Ashraf A, Kuhlman R, Khan O, Nusrat S. Successful immune tolerance induction using efanesoctocog alfa in severe hemophilia A: a case series. Journal of Thrombosis and Haemostasis. 2026;24(11):3939-3942. doi:10.1016/j.jtha.2026.08.022
BibTeX
@article{Ashraf2026,
author = {Ashraf, Aqsa and Kuhlman, Rebekah and Khan, Osman and Nusrat, Sanober},
title = {Successful immune tolerance induction using efanesoctocog alfa in severe hemophilia A: a case series},
journal = {Journal of Thrombosis and Haemostasis},
year = {2026},
volume = {24},
number = {11},
pages = {3939--3942},
doi = {10.1016/j.jtha.2026.08.022}
}
EUVIMED